Dr. Amira Al-Uzri, M.D. – FDA Inspection, Jun 18, 2026

Record Details

This FDA Inspection record concerns Dr. Amira Al-Uzri, M.D., with an inspection on June 18, 2026, issued by the Seattle District Office, covering human drugs.

Company: Dr. Amira Al-Uzri, M.D.
Inspection Date: June 18, 2026
Product Type: Human Drugs
Office: Seattle District Office
People: Gavin W. Pierce (Issuing Officer)
Theressa B. Smith (Issuing Officer)

View Company Profile

ID · 7ee07ab5-b309-47aa-a8df-6907645c1ad3

Inspection Facts

Inspection number: 1323272
FDA center: Human Drugs
Project area: Bioresearch Monitoring
Outcome: Form 483 issued, view the record

FDA Citations

21 CFR 312.62(b)Case history records- inadequate or inadequate
21 CFR 312.62(c)Record retention
21 CFR 50.55(e)(2)Two parents' permission: studies under Parts 50.53 - 50.54

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Dr. Amira Al-Uzri, M.D.

FDA Inspection

Dr. Amira Al-Uzri, M.D.June 18, 2026